IMVT
IMVT
NASDAQ · Biotechnology

Immunovant Inc

$37.18
+0.23 (+0.62%)
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Buy 18 78%
Hold 5 22%
Sell 0 0%
Price Target
Analyst Price Target +63.9% upside
Low Target $43.15
Average Target $60.94
High Target $94.48
Current Price $37.18
Current
$37.18
Target
$60.94
$43.15 $60.94 avg $94.48
Scenario Analysis
Bear Case
$43.15
16.1%
Low target
Base Case
$60.94
+63.9%
Avg target
Bull Case
$94.48
+154.1%
High target
Risk/Reward
9.6x
Highly favorable
Price in Context
52-Week High
$45.42
-18.1% from high
52-Week Low
$14.58
+155.0% from low
50-Day SMA
$25.99
+43.1% vs SMA
200-Day SMA
$19.59
+89.8% vs SMA
RSI (14)
49.5
Neutral
Target vs 52W High
$60.94
+34.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.6%
AMGN
Amgen Inc
Hold 43 47% $190.87 -51.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +140.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.2%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%